P913: LOW-DOSE BELANTAMAB MAFODOTIN (BELAMAF) IN COMBINATION WITH NIROGACESTAT VS BELAMAF MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1/2 DREAMM-5 PLATFORM SUB-STUDY 3

Autor: Natalie Callander, Paul Richardson, Marek Hus, Vincent Ribrag, Joaquín Martinez-Lopez, Kihyun Kim, Jae Hoon Lee, Meletios A. Dimopoulos, Fredrik Schjesvold, Thierry Facon, Jae-Cheol Jo, Chang-Ki Min, Michał Mielnik, Shinta Cheng, Mary Smith, Caroline J. Breitbach, Chris Brawley, Harjeet Sembhi, John Lamacchia, Sebastian Grosicki
Jazyk: angličtina
Rok vydání: 2023
Předmět:
Zdroj: HemaSphere, Vol 7, p e9722122 (2023)
Druh dokumentu: article
ISSN: 2572-9241
DOI: 10.1097/01.HS9.0000970556.97221.22
Databáze: Directory of Open Access Journals